ALG-055009 in Non-cirrhotic Adults With MASH (HERALD)

PHASE2CompletedINTERVENTIONAL
Enrollment

102

Participants

Timeline

Start Date

April 1, 2024

Primary Completion Date

August 19, 2024

Study Completion Date

September 9, 2024

Conditions
NASHMASHMetabolic Dysfunction-Associated SteatohepatitisNonalcoholic Steatohepatitis
Interventions
DRUG

ALG-055009

Softgel Capsule

DRUG

Placebo

Softgel Capsule

Trial Locations (40)

10001

Aligos Clinical Study Site 7, New York

20108

Aligos Clinical Study Site 13, Manassas

28557

Aligos Clinical Study Site 8, Morehead City

30601

Aligos Clinical Study Site 23, Athens

32119

Aligos Clinical Study Site 32, Port Orange

32159

Aligos Clinical Study Site 31, The Villages

32703

Aligos Clinical Study Site 22, Ocoee

32789

Aligos Clinical Study Site 30, Winter Park

32924

Aligos Clinical Study Site 3, Viera

33755

Aligos Clinical Study Site 25, Clearwater

33901

Aligos Clinical Study Site 39, Fort Myers

34205

Aligos Clinical Study Site 26, Bradenton

34230

Aligos Clinical Study Site 38, Sarasota

37011

Aligos Clinical Study Site 9, Nashville

40018

Aligos Clinical Study Site 29, Louisville

43004

Aligos Clinical Study Site 21, Columbus

44145

Aligos Clinical Study Site 16, Westlake

48047

Aligos Clinical Study Site 14, Chesterfield

66546

Aligos Clinical Study Site 12, Topeka

70001

Aligos Clinical Study Site 6, Metairie

70072

Aligos Clinical Study Site 4, Marrero

70360

Aligos Clinical Study Site 5, Houma

71220

Aligos Clinical Study Site 24, Bastrop

73301

Aligos Clinical Study Site 19, Austin

75006

Aligos Clinical Study Site 40, Farmers Branch

76633

Aligos Clinical Study Site 11, Waco

77401

Aligos Clinical Study Site 33, Bellaire

78015

Aligos Clinical Study Site 20, San Antonio

78504

Aligos Clinical Study Site 28, Edinburg

78520

Aligos Clinical Study Site 27, Brownsville

85224

Aligos Clinical Study Site 18, Chandler

85301

Aligos Clinical Study Site 15, Peoria

85641

Aligos Clinical Study Site 17, Tucson

91902

Aligos Clinical Study Site 35, Chula Vista

92025

Aligos Clinical Study Site 37, Poway

92316

Aligos Clinical Study Site 10, Rialto

95648

Aligos Clinical Study Site 1, Lincoln

98039

Aligos Clinical Study Site 34, Seattle

32751, 32794

Aligos Clinical Study Site 2, Maitland

02818

Aligos Clinical Study Site 36, East Greenwich

Sponsors
All Listed Sponsors
lead

Aligos Therapeutics

INDUSTRY

NCT06342947 - ALG-055009 in Non-cirrhotic Adults With MASH (HERALD) | Biotech Hunter | Biotech Hunter